A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status

Update Il y a 4 ans
Reference: NCT01271010

Woman and Man

Extract

This multi-center, single-arm study will evaluate the efficacy and safety of rituximab in combination with fludarabine and cyclophosphamide in participants with B-cell chronic lymphocytic leukemia (CLL) and favorable somatic status.


Inclusion criteria

  • Lymphocytic Leukemia, Chronic

Links